250 related articles for article (PubMed ID: 31434946)
1. Extracorporeal shock waves protect cardiomyocytes from doxorubicin-induced cardiomyopathy by upregulating survivin via the integrin-ILK-Akt-Sp1/p53 axis.
Yoon Lee J; Chung J; Hwa Kim K; Hyun An S; Yi JE; Ae Kwon K; Kwon K
Sci Rep; 2019 Aug; 9(1):12149. PubMed ID: 31434946
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Protect Cardiomyocytes from Doxorubicin-Induced Cardiomyopathy by Upregulating Survivin Expression via the miR-199a-3p-Akt-Sp1/p53 Signaling Pathway.
Lee JY; Chung J; Byun Y; Kim KH; An SH; Kwon K
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281156
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways.
Mantawy EM; Esmat A; El-Bakly WM; Salah ElDin RA; El-Demerdash E
Sci Rep; 2017 Jul; 7(1):4795. PubMed ID: 28684738
[TBL] [Abstract][Full Text] [Related]
4. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.
Venkatesan B; Prabhu SD; Venkatachalam K; Mummidi S; Valente AJ; Clark RA; Delafontaine P; Chandrasekar B
Cell Signal; 2010 May; 22(5):809-20. PubMed ID: 20074638
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin protects cardiomyocyte from doxorubicin toxicity by modulating survivin expression through FOXO1 inhibition.
Oh J; Lee BS; Lim G; Lim H; Lee CJ; Park S; Lee SH; Chung JH; Kang SM
J Mol Cell Cardiol; 2020 Jan; 138():244-255. PubMed ID: 31866378
[TBL] [Abstract][Full Text] [Related]
6. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
[TBL] [Abstract][Full Text] [Related]
7. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway.
Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Guo DM; He H; Peng J; Tang ZH; Jiang ZS
Int J Mol Med; 2016 Jun; 37(6):1661-8. PubMed ID: 27081862
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity.
Fan GC; Zhou X; Wang X; Song G; Qian J; Nicolaou P; Chen G; Ren X; Kranias EG
Circ Res; 2008 Nov; 103(11):1270-9. PubMed ID: 18948619
[TBL] [Abstract][Full Text] [Related]
10. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
[TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
[TBL] [Abstract][Full Text] [Related]
12. C1qTNF-related protein-6 protects against doxorubicin-induced cardiac injury.
Zheng WF; Zhang SY; Ma HF; Chang XW; Wang H
J Cell Biochem; 2019 Jun; 120(6):10748-10755. PubMed ID: 30719766
[TBL] [Abstract][Full Text] [Related]
13. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
14. Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction.
Tian XQ; Ni XW; Xu HL; Zheng L; ZhuGe DL; Chen B; Lu CT; Yuan JJ; Zhao YZ
Int J Nanomedicine; 2017; 12():7103-7119. PubMed ID: 29026304
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol protects cardiomyocytes from doxorubicin-induced apoptosis through the AMPK/P53 pathway.
Liu MH; Lin XL; Guo DM; Zhang Y; Yuan C; Tan TP; Chen YD; Wu SJ; Ye ZF; He J
Mol Med Rep; 2016 Feb; 13(2):1281-6. PubMed ID: 26675978
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of cardiac phosphatidylinositol 3-kinase (PI3K)/Akt signaling by apoptosis regulator through modulating IAP expression (ARIA) regulates cardiomyocyte death during doxorubicin-induced cardiomyopathy.
Kitamura Y; Koide M; Akakabe Y; Matsuo K; Shimoda Y; Soma Y; Ogata T; Ueyama T; Matoba S; Yamada H; Ikeda K
J Biol Chem; 2014 Jan; 289(5):2788-800. PubMed ID: 24338479
[TBL] [Abstract][Full Text] [Related]
17. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin-1 attenuates doxorubicin-induced autophagy in neonatal rat cardiomyocytes.
An T; Huang Y; Zhou Q; Wei BQ; Zhang RC; Yin SJ; Zou CH; Zhang YH; Zhang J
J Cardiovasc Pharmacol; 2013 Aug; 62(2):130-7. PubMed ID: 23519142
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor attenuates doxorubicin-induced cardiac dysfunction through activating Akt signalling in rats.
Hang P; Zhao J; Sun L; Li M; Han Y; Du Z; Li Y
J Cell Mol Med; 2017 Apr; 21(4):685-696. PubMed ID: 28098423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
